Ma Pei, Zhang Sen, Su Xinlin, Qiu Guixing, Wu Zhihong
Department of Orthopaedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, 100730, China ; State key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, 100050, China.
State key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, 100050, China.
Am J Transl Res. 2015 Oct 15;7(10):2105-14. eCollection 2015.
Cisplatin chemotherapy often causes acute kidney injury in cancer patients. Icariin is a bioactive flavonoid, which has renal protection and anti-inflammation effects. This study investigated the mechanism underlying the attenuation of cisplatin-induced renal injury by icariin. BALB/c mice were treated with cisplatin (15 mg/kg) with or without treatment with icariin (30 or 60 mg/kg for 5 days). Renal function, histological changes, degree of oxidative stress and tubular apoptosis were examined. The effects of icariin on cisplatin-induced expression of renal TNF-α, NF-κB, cleaved caspase-3 and Bcl-2 family proteins were evaluated. Treatment of mice with cisplatin resulted in renal damage, showing an increase in blood urea nitrogen and creatinine levels, tubular damage, oxidative stress and apoptosis. These renal changes could be significantly improved by icariin treatment, especially in high dose of icariin group. Examination of molecules involving inflammation and apoptosis of the kidney revealed that treatment of icariin reduced expression of TNF-α, NF-κB, cleaved caspase-3, and Bax, increased the expression of BCL-2. These results indicate that icariin ameliorates the cisplatin-mediated nephrotoxicity via improving renal oxidant status, consequent NF-κB activation and inflammation cascade and apoptosis, and the following disturbed expression of apoptosis related proteins.
顺铂化疗常常会导致癌症患者出现急性肾损伤。淫羊藿苷是一种具有生物活性的黄酮类化合物,具有肾脏保护和抗炎作用。本研究探讨了淫羊藿苷减轻顺铂诱导的肾损伤的机制。将BALB/c小鼠用顺铂(15毫克/千克)处理,同时或不并用淫羊藿苷(30或60毫克/千克,持续5天)。检测肾功能、组织学变化、氧化应激程度和肾小管凋亡情况。评估淫羊藿苷对顺铂诱导的肾脏肿瘤坏死因子-α(TNF-α)、核因子-κB(NF-κB)、裂解的半胱天冬酶-3(cleaved caspase-3)和Bcl-2家族蛋白表达的影响。用顺铂处理小鼠导致肾脏损伤,表现为血尿素氮和肌酐水平升高、肾小管损伤、氧化应激和凋亡。淫羊藿苷处理可显著改善这些肾脏变化,尤其是在高剂量淫羊藿苷组。对涉及肾脏炎症和凋亡的分子进行检测发现,淫羊藿苷处理可降低TNF-α、NF-κB、cleaved caspase-3和Bax的表达,增加BCL-2的表达。这些结果表明,淫羊藿苷通过改善肾脏氧化状态、随之而来的NF-κB激活和炎症级联反应以及凋亡,以及随后凋亡相关蛋白表达紊乱,减轻顺铂介导的肾毒性。